(A Top Pick March 13/17. Up 20%.) ROIC 15%+ for 20 years and now 20%. A technology play backed by the U.S. government. Valuation good plus decent dividend. This is a classic return on invested capital.

Cleaned up their balance sheet. Still have a lot of debt though they've reigned it in. ROIC went from -8% to 3% in just two years. They're doing the right things.

Issues about competition with its drugs. Earns 26% ROIC, EBITDA has come down. In a good area, including oncology and HIV. A good pipeline, cash flow and valuations. Likes it a lot.

A great company, but pause on the utilities space for now given rising interest rates. Now's a good time to sell then buy cheaper later for all utilities.

Likes golds, but Eldorado's ROIC negative and still lags compared to everyone else in this space. There should be positive returns at this point in the cycle.

A lot of pressure from Amazon getting into CVS' space, but confident CVS will emerge well. CVS will fight back. But don't get too speculative on events (Amazon) that could happen. ROIC consistent. Good valuation. He has faith in CVS.

His least favourite FANG. Prefers Amazon and Facebook. ROIC was 29% in 2012 at peak, but now 13%. How long can they milk the iPhone? Victim of their own success. They have so much cash sitting overseas. Will they invest it? Repurchase shares and pay a dividend would be his suggestion.